Second, AKT agonist sc-79 should be administrated in rat IDD model to confirm that DHA attenuated IDD via inhibiting PI3K/AKT and NF-κB signaling pathways in vivo, which is our next step. This evidence concerns the gene AKT1 and intervertebral disk degenerative disorder.